440 related articles for article (PubMed ID: 35016680)
1. Notch4 mediates vascular remodeling via ERK/JNK/P38 MAPK signaling pathways in hypoxic pulmonary hypertension.
Guo M; Zhang M; Cao X; Fang X; Li K; Qin L; He Y; Zhao J; Xu Y; Liu X; Li X
Respir Res; 2022 Jan; 23(1):6. PubMed ID: 35016680
[TBL] [Abstract][Full Text] [Related]
2. TRB3 mediates vascular remodeling by activating the MAPK signaling pathway in hypoxic pulmonary hypertension.
Cao X; Fang X; Guo M; Li X; He Y; Xie M; Xu Y; Liu X
Respir Res; 2021 Dec; 22(1):312. PubMed ID: 34906150
[TBL] [Abstract][Full Text] [Related]
3. MiR-593-5p promotes the development of hypoxic-induced pulmonary hypertension via targeting PLK1.
Zhao TF; Wang SY; Zou XZ; Zhao HD
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3495-3502. PubMed ID: 31081105
[TBL] [Abstract][Full Text] [Related]
4. The effect of activated κ-opioid receptor (κ-OR) on the role of calcium sensing receptor (CaSR) in preventing hypoxic pulmonary hypertension development.
Li J; Jia M; Liu M; Cao Z; Wang X; Feng N; Gu X; Zhang S; Fan R; Guo H; Wang Y; Liu M; Pei J
Biomed Pharmacother; 2020 May; 125():109931. PubMed ID: 32066040
[TBL] [Abstract][Full Text] [Related]
5. Exosomes derived from mesenchymal stromal cells exert a therapeutic effect on hypoxia-induced pulmonary hypertension by modulating the YAP1/SPP1 signaling pathway.
Chen YX; Deng ZH; Xue-Gao ; Qiang-Du ; Juan-Yin ; Chen GH; Li JG; Zhao YM; Zhang HT; Zhang GX; Qian JX
Biomed Pharmacother; 2023 Dec; 168():115816. PubMed ID: 37918254
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis reveals that Xbp1s promotes hypoxic pulmonary hypertension through the p-JNK MAPK pathway.
Jiang H; Niu Y; He Y; Li X; Xu Y; Liu X
J Cell Physiol; 2022 Mar; 237(3):1948-1963. PubMed ID: 34964131
[TBL] [Abstract][Full Text] [Related]
7. The alveolar epithelial cells are involved in pulmonary vascular remodeling and constriction of hypoxic pulmonary hypertension.
Wang Y; Li X; Niu W; Chen J; Zhang B; Zhang X; Wang Y; Dang S; Li Z
Respir Res; 2021 May; 22(1):134. PubMed ID: 33947399
[TBL] [Abstract][Full Text] [Related]
8. Involvement of Gax gene in hypoxia-induced pulmonary hypertension, proliferation, and apoptosis of arterial smooth muscle cells.
Xia S; Tai X; Wang Y; An X; Qian G; Dong J; Wang X; Sha B; Wang D; Murthi P; Kalionis B; Wang X; Bai C
Am J Respir Cell Mol Biol; 2011 Jan; 44(1):66-73. PubMed ID: 20160044
[TBL] [Abstract][Full Text] [Related]
9. NDUFA4L2 in smooth muscle promotes vascular remodeling in hypoxic pulmonary arterial hypertension.
Liu Y; Nie X; Zhu J; Wang T; Li Y; Wang Q; Sun Z
J Cell Mol Med; 2021 Jan; 25(2):1221-1237. PubMed ID: 33340241
[TBL] [Abstract][Full Text] [Related]
10. Nur77 induced by HIF-1α mediates vascular remodeling in hypoxic pulmonary hypertension.
Mao C; Huang J; Liu H; Liu Y; Hu Z; Xu R
Cell Mol Biol (Noisy-le-grand); 2024 Jun; 70(6):233-237. PubMed ID: 38836656
[TBL] [Abstract][Full Text] [Related]
11. Reoxygenation Reverses Hypoxic Pulmonary Arterial Remodeling by Inducing Smooth Muscle Cell Apoptosis via Reactive Oxygen Species-Mediated Mitochondrial Dysfunction.
Chen J; Wang YX; Dong MQ; Zhang B; Luo Y; Niu W; Li ZC
J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28645933
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of dioscin on vascular remodeling in pulmonary arterial hypertension via adjusting GRB2/ERK/PI3K-AKT signal.
Yang Y; Yin L; Zhu M; Song S; Sun C; Han X; Xu Y; Zhao Y; Qi Y; Xu L; Peng JY
Biomed Pharmacother; 2021 Jan; 133():111056. PubMed ID: 33378960
[TBL] [Abstract][Full Text] [Related]
13. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
[TBL] [Abstract][Full Text] [Related]
14. DUSP5-mediated inhibition of smooth muscle cell proliferation suppresses pulmonary hypertension and right ventricular hypertrophy.
Ferguson BS; Wennersten SA; Demos-Davies KM; Rubino M; Robinson EL; Cavasin MA; Stratton MS; Kidger AM; Hu T; Keyse SM; McKnight RA; Lane RH; Nozik ES; Weiser-Evans MCM; McKinsey TA
Am J Physiol Heart Circ Physiol; 2021 Aug; 321(2):H382-H389. PubMed ID: 34142888
[TBL] [Abstract][Full Text] [Related]
15. Methylation-mediated silencing of PTPRD induces pulmonary hypertension by promoting pulmonary arterial smooth muscle cell migration via the PDGFRB/PLCγ1 axis.
Xu J; Zhong Y; Yin H; Linneman J; Luo Y; Xia S; Xia Q; Yang L; Huang X; Kang K; Wang J; Niu Y; Li L; Gou D
J Hypertens; 2022 Sep; 40(9):1795-1807. PubMed ID: 35848503
[TBL] [Abstract][Full Text] [Related]
16. CYLD mediates human pulmonary artery smooth muscle cell dysfunction in congenital heart disease-associated pulmonary arterial hypertension.
Zhou JJ; Li H; Li L; Li Y; Wang PH; Meng XM; He JG
J Cell Physiol; 2021 Sep; 236(9):6297-6311. PubMed ID: 33507567
[TBL] [Abstract][Full Text] [Related]
17. Involvement of Ca
Guo S; Shen Y; He G; Wang T; Xu D; Wen F
Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28679649
[TBL] [Abstract][Full Text] [Related]
18. Resistin-like molecule β acts as a mitogenic factor in hypoxic pulmonary hypertension via the Ca
Tian H; Liu L; Wu Y; Wang R; Jiang Y; Hu R; Zhu L; Li L; Fang Y; Yang C; Ji L; Liu G; Dai A
Respir Res; 2021 Jan; 22(1):8. PubMed ID: 33407472
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary artery smooth muscle cell endothelin-1 expression modulates the pulmonary vascular response to chronic hypoxia.
Kim FY; Barnes EA; Ying L; Chen C; Lee L; Alvira CM; Cornfield DN
Am J Physiol Lung Cell Mol Physiol; 2015 Feb; 308(4):L368-77. PubMed ID: 25399435
[TBL] [Abstract][Full Text] [Related]
20. Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation.
Zhang L; Wang Y; Wu G; Rao L; Wei Y; Yue H; Yuan T; Yang P; Xiong F; Zhang S; Zhou Q; Chen Z; Li J; Mo BW; Zhang H; Xiong W; Wang CY
Cell Prolif; 2020 Feb; 53(2):e12742. PubMed ID: 31943454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
